TY - JOUR
T1 - On the horns of a dilemma
T2 - choosing total intravenous anaesthesia or volatile anaesthesia
AU - Riedel, Bernhard
AU - Dubowitz, Julia
AU - Yeung, Joyce
AU - Jhanji, Shaman
AU - Kheterpal, Sachin
AU - Avidan, Michael S.
N1 - Publisher Copyright:
© 2022 British Journal of Anaesthesia
PY - 2022/9
Y1 - 2022/9
N2 - There are two established techniques of delivering general anaesthesia: propofol-based total intravenous anaesthesia (TIVA) and volatile agent-based inhaled anaesthesia. Both techniques are offered as standard of care and have an established safety track record lasting more than 30 years. However, it is not currently known whether the choice of anaesthetic technique results in a fundamentally different patient experience or affects early, intermediate-term, and longer-term postoperative outcomes. This editorial comments on a recently published study that suggests that inhaled volatile anaesthesia might be associated with fewer postoperative surgical complications than propofol-based TIVA for patients undergoing colorectal cancer surgery. We consider the strengths and limitations of the study, place these findings in the context of the broader evidence, and discuss how the current controversies regarding anaesthetic technique can be resolved, thereby helping to bring precision medicine into the modern practice of perioperative care.
AB - There are two established techniques of delivering general anaesthesia: propofol-based total intravenous anaesthesia (TIVA) and volatile agent-based inhaled anaesthesia. Both techniques are offered as standard of care and have an established safety track record lasting more than 30 years. However, it is not currently known whether the choice of anaesthetic technique results in a fundamentally different patient experience or affects early, intermediate-term, and longer-term postoperative outcomes. This editorial comments on a recently published study that suggests that inhaled volatile anaesthesia might be associated with fewer postoperative surgical complications than propofol-based TIVA for patients undergoing colorectal cancer surgery. We consider the strengths and limitations of the study, place these findings in the context of the broader evidence, and discuss how the current controversies regarding anaesthetic technique can be resolved, thereby helping to bring precision medicine into the modern practice of perioperative care.
KW - TIVA
KW - inhalational anaesthesia
KW - postoperative complications
KW - postoperative outcomes
KW - precision medicine
KW - propofol
KW - total intravenous anaesthesia
KW - volatile anaesthesia
UR - http://www.scopus.com/inward/record.url?scp=85134297802&partnerID=8YFLogxK
U2 - 10.1016/j.bja.2022.06.008
DO - 10.1016/j.bja.2022.06.008
M3 - Editorial
C2 - 35835606
AN - SCOPUS:85134297802
SN - 0007-0912
VL - 129
SP - 284
EP - 289
JO - British journal of anaesthesia
JF - British journal of anaesthesia
IS - 3
ER -